Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Bonnet

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
British Journal of Pharmacology|November 1, 1993
Cardiovascular effects of SCA40, a novel potassium channel opener, in ratsA Michel, F Laurent, J Bompart, et al.
British Journal of Pharmacology|September 1, 1996
Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalimJ Cortijo, V Villagrasa, C Navarrete, et al.
Journal of Medicinal Chemistry|September 4, 1992
Synthesis and antibronchospastic activity of 8-alkoxy- and 8-(alkylamino)imidazo[1,2-a]pyrazinesP A Bonnet, A Michel, F Laurent, et al.
Magnetic Resonance Imaging|January 1, 1990
The use of Gd-DOTA in magnetic resonance imaging of experimentally induced mammary tumorsP A Bonnet, A Michel, J P Fernandez, et al.
Journal De Radiologie|December 1, 1984
[Contrast agents in magnetic resonance imaging]P A Bonnet, J P Fernandez, J C Milhavet, et al.
Annales Pharmaceutiques Francaises|October 14, 1998
[SCA 40 and derivatives: new bronchodilators in an imidazo(1,2-a)pyrazine series]P A Bonnet, O Vitse, V Bénezech, et al.
European Journal of Pharmacology|November 5, 1997
Effects of SCA40 on bovine trachealis muscle and on cyclic nucleotide phosphodiesterasesT M Pocock, F Laurent, L M Isaac, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
New imidazo(1,2-a)pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activitiesO Vitse, F Laurent, T M Pocock, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
British Journal of Pharmacology|November 1, 1993
Cardiovascular effects of SCA40, a novel potassium channel opener, in ratsA Michel, F Laurent, J Bompart, et al.
British Journal of Pharmacology|September 1, 1996
Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalimJ Cortijo, V Villagrasa, C Navarrete, et al.
Journal of Medicinal Chemistry|September 4, 1992
Synthesis and antibronchospastic activity of 8-alkoxy- and 8-(alkylamino)imidazo[1,2-a]pyrazinesP A Bonnet, A Michel, F Laurent, et al.
Magnetic Resonance Imaging|January 1, 1990
The use of Gd-DOTA in magnetic resonance imaging of experimentally induced mammary tumorsP A Bonnet, A Michel, J P Fernandez, et al.
Journal De Radiologie|December 1, 1984
[Contrast agents in magnetic resonance imaging]P A Bonnet, J P Fernandez, J C Milhavet, et al.
Annales Pharmaceutiques Francaises|October 14, 1998
[SCA 40 and derivatives: new bronchodilators in an imidazo(1,2-a)pyrazine series]P A Bonnet, O Vitse, V Bénezech, et al.
European Journal of Pharmacology|November 5, 1997
Effects of SCA40 on bovine trachealis muscle and on cyclic nucleotide phosphodiesterasesT M Pocock, F Laurent, L M Isaac, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
New imidazo(1,2-a)pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activitiesO Vitse, F Laurent, T M Pocock, et al.
Pageof 3